Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted...
Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.445 | 4.22602089269 | 10.53 | 11.92 | 10.1101 | 488097 | 10.80115047 | CS |
4 | -1.475 | -11.8473895582 | 12.45 | 12.985 | 9.5005 | 522969 | 10.81799914 | CS |
12 | -4.865 | -30.7133838384 | 15.84 | 17.5034 | 9.5005 | 575311 | 12.43290831 | CS |
26 | -8.425 | -43.4278350515 | 19.4 | 19.89 | 9.5005 | 558604 | 15.07638992 | CS |
52 | -3.475 | -24.0484429066 | 14.45 | 30.1886 | 9.5005 | 652046 | 18.02949697 | CS |
156 | -1.745 | -13.7185534591 | 12.72 | 30.1886 | 7.3 | 385916 | 14.99761225 | CS |
260 | -31.025 | -73.869047619 | 42 | 59.85 | 7.3 | 353575 | 17.65280503 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관